|Bid||3.05 x 4500|
|Ask||4.95 x 100|
|Day's Range||3.11 - 3.35|
|52 Week Range||1.10 - 5.30|
|PE Ratio (TTM)||-2.81|
|Earnings Date||May 11, 2017 - May 12, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||7.67|
Q2 2017 Cancer Genetics Inc Earnings Call
NEW YORK, NY / ACCESSWIRE / August 16, 2017 / Cancer Genetics traders sold off in Tuesday trading after the company hit as high as $3.90 on Monday after announcing second quarter financial results and ...
RUTHERFORD, N.J. and LOS ANGELES, Aug. 16, 2017-- Cancer Genetics, Inc., a leader in enabling precision medicine for oncology through molecular markers and diagnostics, announced today that it will host ...